Please Scroll Down to See Forums Below Hey all I sometimes have problems with the sides on Chlomid during PCT. I was wondering if it is possibly to switch from chlomid to nolvadex during PCT. My sides usually start popping up around day 16 of PCT. Would I be able to just drop it and them start using nolva, and at what amount?
Going from Chlomid to Nolva in PCT?
- Thread starter KayKo
- Start date
shamrock11
New member
I don't see it being a problem. They are very similar chemicals with similar functions. I've seen some PCT that use clomid for three weeks and the nolva. What dosages ae you using?
Thanks for the feedback bro. As for chlomid dosages, I use 300mgs 1st day, 100mgs for next 10 days, and then 50 mgs for the next 10 days. Usually by the middle of the 100mg dosage, I feel like total crap and depressed. What dosage can I switch to in regards to nolva to finish out the PCT? Would I still be doing the 21 day PCT or would I have to extend the PCT due to switching over to nolva?
shamrock11
New member
Mood changes are a side of clomid, I would just say deal with it if you can, but if not finish off the 100mg doses then switch to nolva and do that for two to three weeks.
iamnikvanhelsing
New member
Well I'm no vet but from all the info i've researched I see no indications that Nolva helps your boys get back in shape. Nolva is a treatment for breast cancer and its only effects are at the Estrogen receptor etc. Clomiphene Citrate (clomid) on the other hand is used to stimulate the reproductive organs of both men and women i.e. ovarys and testicles.
So with this in mind why would you believe Nolva helps your nuts recover after a cycle? Do you have evidence that suggests this?
Nolva is for Gyno, Clomid is for Nutz! Just what my research revealed.
So with this in mind why would you believe Nolva helps your nuts recover after a cycle? Do you have evidence that suggests this?
Nolva is for Gyno, Clomid is for Nutz! Just what my research revealed.
fugetaboutit
New member
Nolva helps you restore your natural test levels. It's not just for breast cancer or just to combat gyno.
iamnikvanhelsing
New member
Tamoxifen (Novladex®)
Metastatic Breast Cancer: NOLVADEX is effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, NOLVADEX is an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from NOLVADEX therapy.
Adjuvant Treatment of Breast Cancer: NOLVADEX is indicated for the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some NOLVADEX adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes.
NOLVADEX is indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation.
The estrogen and progesterone receptor values may help to predict whether adjuvant NOLVADEX therapy is likely to be beneficial.
NOLVADEX reduces the occurrence of contralateral breast cancer in patients receiving adjuvant NOLVADEX therapy for breast cancer.
Ductal Carcinoma in Situ (DCIS): In women with DCIS, following breast surgery and radiation, NOLVADEX is indicated to reduce the risk of invasive breast cancer. The decision regarding therapy with NOLVADEX for the reduction in breast cancer incidence should be based upon an individual assessment of the benefits and risk of NOLVADEX therapy.
Current data from clinical trials support five years of adjuvant NOLVADEX therapy for patients with breast cancer.
Reduction in Breast Cancer Incidence in High Risk Women: NOLVADEX is indicated to reduce the incidence of breast cancer in women at high risk for breast cancer. This effect was shown in a study of 5 years planned duration with a median follow-up of 4.2 years. Twenty-five percent of the participants received drug for 5 years. The longer-term effects are not known. In this study, there was no impact of tamoxifen on overall or breast cancer-related mortality.
NOLVADEX is indicated only for high-risk women. “High risk” is defined as women at least 35 years of age with a 5-year predicted risk of breast cancer > 1.67%, as calculated by the Gail Model.
These are the only usages I have come across so far. Can you point me to any official documentation thats states its use for increasing natural test levels? I will stand corrected if so and happily apologise, but I cant find any.
Cheers.
Metastatic Breast Cancer: NOLVADEX is effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, NOLVADEX is an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from NOLVADEX therapy.
Adjuvant Treatment of Breast Cancer: NOLVADEX is indicated for the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some NOLVADEX adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes.
NOLVADEX is indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation.
The estrogen and progesterone receptor values may help to predict whether adjuvant NOLVADEX therapy is likely to be beneficial.
NOLVADEX reduces the occurrence of contralateral breast cancer in patients receiving adjuvant NOLVADEX therapy for breast cancer.
Ductal Carcinoma in Situ (DCIS): In women with DCIS, following breast surgery and radiation, NOLVADEX is indicated to reduce the risk of invasive breast cancer. The decision regarding therapy with NOLVADEX for the reduction in breast cancer incidence should be based upon an individual assessment of the benefits and risk of NOLVADEX therapy.
Current data from clinical trials support five years of adjuvant NOLVADEX therapy for patients with breast cancer.
Reduction in Breast Cancer Incidence in High Risk Women: NOLVADEX is indicated to reduce the incidence of breast cancer in women at high risk for breast cancer. This effect was shown in a study of 5 years planned duration with a median follow-up of 4.2 years. Twenty-five percent of the participants received drug for 5 years. The longer-term effects are not known. In this study, there was no impact of tamoxifen on overall or breast cancer-related mortality.
NOLVADEX is indicated only for high-risk women. “High risk” is defined as women at least 35 years of age with a 5-year predicted risk of breast cancer > 1.67%, as calculated by the Gail Model.
These are the only usages I have come across so far. Can you point me to any official documentation thats states its use for increasing natural test levels? I will stand corrected if so and happily apologise, but I cant find any.
Cheers.
iamnikvanhelsing
New member
Ok I found it:
So which one should you use? Well personally, I'd have to say Nolvadex. Both as an on-cycle anti-estrogen and a post-cycle therapy. As an anti-estrogen its simply much stronger, demonstrated by the fact that better results are obtained with 20-40 mg than with 100-150 mg of clomid. For post-cycle, this plays a key role as well. It deactivates rebound estrogen much faster and more effective. But most importantly, Nolvadex has a direct influence on bringing back natural testosterone, where as clomid may actually have a slight negative influence. The reason being that Tamoxifen (as in Nolvadex) seems to increase the responsiveness of LH (luteinizing hormone) to GnRH (gonadtropin releasing hormone), whereas clomid seems to decrease the responsiveness a bit1.
Another reason why I promote the use of Nolvadex over Clomid post-cycle (as if being 3-4 times stronger and having more of a direct effect on restoring natural test wasn't enough) is because it's a lot safer. Not just because it improves lipid profiles, but also because it simply doesn't have the intrinsic side-effects that Clomid has. Clomid causes more acne for sure, but that's mainly because you need to use a 3-4 times higher dose. But Clomid seems to also affect the eyesight. Long-term clomid therapy causes irreversible changes in eyesight3 in users. Irreversible. For me that alone is reason enough to prefer Nolvadex.
So........I'm chuckin out my Clomid and getting more Tamoxifen!!!!
So which one should you use? Well personally, I'd have to say Nolvadex. Both as an on-cycle anti-estrogen and a post-cycle therapy. As an anti-estrogen its simply much stronger, demonstrated by the fact that better results are obtained with 20-40 mg than with 100-150 mg of clomid. For post-cycle, this plays a key role as well. It deactivates rebound estrogen much faster and more effective. But most importantly, Nolvadex has a direct influence on bringing back natural testosterone, where as clomid may actually have a slight negative influence. The reason being that Tamoxifen (as in Nolvadex) seems to increase the responsiveness of LH (luteinizing hormone) to GnRH (gonadtropin releasing hormone), whereas clomid seems to decrease the responsiveness a bit1.
Another reason why I promote the use of Nolvadex over Clomid post-cycle (as if being 3-4 times stronger and having more of a direct effect on restoring natural test wasn't enough) is because it's a lot safer. Not just because it improves lipid profiles, but also because it simply doesn't have the intrinsic side-effects that Clomid has. Clomid causes more acne for sure, but that's mainly because you need to use a 3-4 times higher dose. But Clomid seems to also affect the eyesight. Long-term clomid therapy causes irreversible changes in eyesight3 in users. Irreversible. For me that alone is reason enough to prefer Nolvadex.
So........I'm chuckin out my Clomid and getting more Tamoxifen!!!!
kimblesaurus
New member
bump
